TY - JOUR
T1 - Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells
AU - Yu, Xue Zhong
AU - Liang, Yaming
AU - Nurieva, Roza I.
AU - Guo, Fei
AU - Anasetti, Claudio
AU - Dong, Chen
PY - 2006/6/15
Y1 - 2006/6/15
N2 - ICOS, a CD28 family member expressed on activated CD4+ and CD8+ T cells, plays important roles in T cell activation and effector function. Here we studied the role of ICOS in graft-vs-host disease (GVHD) mediated by CD4+ or CD8+ T cells in allogeneic bone marrow transplantation. In comparison of wild-type and ICOS-deficient T cells, we found that recipients of ICOS-/- CD4+ T cells exhibited significantly less GVHD morbidity and delayed mortality. ICOS-/- CD4+ T cells had no defect in expansion, but expressed significantly less Fas ligand and produced significantly lower levels of IFN-γ and TNF-α. Thus, ICOS-/- CD4+ T cells were impaired in effector functions that lead to GVHD. In contrast, recipients of ICOS -/- CD8+ T cells exhibited significantly enhanced GVHD morbidity and accelerated mortality. In the absence of ICOS signaling, either using ICOS-deicient donors or ICOS ligand-deficient recipients, the levels of expansion and Tc1 cytokine production of CD8+ T cells were significantly increased. The level of expansion was inversely correlated with the level of apoptosis, suggesting that increased ability of ICOS-/- CD8+ T cells to induce GVHD resulted from the enhanced survival and expansion of those cells. Our findings indicate that ICOS has paradoxical effects on the regulation of alloreactive CD4+ and CD8+ T cells in GVHD.
AB - ICOS, a CD28 family member expressed on activated CD4+ and CD8+ T cells, plays important roles in T cell activation and effector function. Here we studied the role of ICOS in graft-vs-host disease (GVHD) mediated by CD4+ or CD8+ T cells in allogeneic bone marrow transplantation. In comparison of wild-type and ICOS-deficient T cells, we found that recipients of ICOS-/- CD4+ T cells exhibited significantly less GVHD morbidity and delayed mortality. ICOS-/- CD4+ T cells had no defect in expansion, but expressed significantly less Fas ligand and produced significantly lower levels of IFN-γ and TNF-α. Thus, ICOS-/- CD4+ T cells were impaired in effector functions that lead to GVHD. In contrast, recipients of ICOS -/- CD8+ T cells exhibited significantly enhanced GVHD morbidity and accelerated mortality. In the absence of ICOS signaling, either using ICOS-deicient donors or ICOS ligand-deficient recipients, the levels of expansion and Tc1 cytokine production of CD8+ T cells were significantly increased. The level of expansion was inversely correlated with the level of apoptosis, suggesting that increased ability of ICOS-/- CD8+ T cells to induce GVHD resulted from the enhanced survival and expansion of those cells. Our findings indicate that ICOS has paradoxical effects on the regulation of alloreactive CD4+ and CD8+ T cells in GVHD.
UR - http://www.scopus.com/inward/record.url?scp=33744913796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744913796&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.176.12.7394
DO - 10.4049/jimmunol.176.12.7394
M3 - Article
C2 - 16751384
AN - SCOPUS:33744913796
SN - 0022-1767
VL - 176
SP - 7394
EP - 7401
JO - Journal of Immunology
JF - Journal of Immunology
IS - 12
ER -